Propanc Biopharma, Inc. Common Stock financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

프로팽크 바이오파머NASDAQ:PPCB · Nasdaq

$0.5000-1.48%

2026-10-05 close

Propanc Biopharma, Inc. Common Stock's published financial data is dated 2026-10-04. 2025 revenue was $0M. 2025 operating profit was −$58M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy